The new EU Veterinary Medicinal Products Regulation, which entered into force on 27/01/2019, is applicable from 28/01/2022. According to Article 9 of this Regulation, applications for approval of clinical trials of veterinary medicinal products shall be submitted to the competent authority of the Member State in which the clinical trial is to be conducted.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that a pathogenic variant in the PHA gene has been identified in donor 8458-IDOR and that he is a carrier of PKU (phenylketonuria).

The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2022/2023 (published 29 March 2022).

Following reports of adverse effects in animals, BASG draws attention to the fact that precautions should be taken to avoid contact of pets with hormone-containing drugs used on the skin of humans.

Recall due to nitrosamine contamination above the permitted daily dose

The BASG warns against the product "Diox Teadetox" due to the non-declaration of the ingredient sibutramine.

The Federal Office for Safety in Health Care has been notified by the Finnish authority that dark colored particles have been detected in Haemonetics Platelet Filter System ATSBC1EB products with lot numbers 215003, 2150070, 2150071, 2150091.

Recall due to usage of a microbiologically contaminated excipient

Clinical studies and the war in Ukraine - Information for Consumers.

Clinical studies and the war in Ukraine - Information for Healthcare Professionals.